Test 251124

The chart shows the growth of an initial investment of $10,000 in Test 251124, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

Based on dividend-adjusted daily data since Feb 7, 2024, Test 251124's average daily return is +0.18%, while the average monthly return is +3.67%. At this rate, an investment would double in approximately 1.6 years.

Historically, 66% of months were positive and 34% were negative. The best month was Sep 2025 with a return of +29.2%, while the worst month was Mar 2026 at -11.6%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 3 months.

On a daily basis, Test 251124 closed higher 53% of trading days. The best single day was Apr 9, 2025 with a return of +7.5%, while the worst single day was Jan 27, 2025 at -8.8%.

Test 251124 has an annualized alpha of 24.04%, beta of 1.06, and R2 of 0.27 versus S&P 500 Index. Calculated based on daily prices since February 07, 2024.

• This portfolio captured 201.19% of S&P 500 Index gains and 110.24% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.27 means this portfolio moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Test 251124 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Test 251124 ranks 19 for risk / return — in the bottom 19% of Portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below presents risk-adjusted performance metrics for Test 251124 and compares them with S&P 500 Index.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Test 251124 Sharpe ratios as of Jun 9, 2026 (values are recalculated daily):

• 1-Year: 1.34
• All Time: 1.50

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.59 to 2.46, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Test 251124 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Test 251124 provided a 0.72% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Test 251124. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Test 251124 was 23.96%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Test 251124 drawdown is 14.48%.

The chart below shows the rolling one-month volatility.